Literature DB >> 30838976

Circular synthesized CRISPR/Cas gRNAs for functional interrogations in the coding and noncoding genome.

Martin Wegner1, Valentina Diehl1, Verena Bittl1,2, Rahel de Bruyn1, Svenja Wiechmann1,3, Yves Matthess1, Marie Hebel1, Michael Gb Hayes4, Simone Schaubeck1, Christopher Benner4, Sven Heinz4, Anja Bremm1,2, Ivan Dikic1,2,5,6, Andreas Ernst1,3, Manuel Kaulich1,5,6.   

Abstract

Current technologies used to generate CRISPR/Cas gene perturbation reagents are labor intense and require multiple ligation and cloning steps. Furthermore, increasing gRNA sequence diversity negatively affects gRNA distribution, leading to libraries of heterogeneous quality. Here, we present a rapid and cloning-free mutagenesis technology that can efficiently generate covalently-closed-circular-synthesized (3Cs) CRISPR/Cas gRNA reagents and that uncouples sequence diversity from sequence distribution. We demonstrate the fidelity and performance of 3Cs reagents by tailored targeting of all human deubiquitinating enzymes (DUBs) and identify their essentiality for cell fitness. To explore high-content screening, we aimed to generate the largest up-to-date gRNA library that can be used to interrogate the coding and noncoding human genome and simultaneously to identify genes, predicted promoter flanking regions, transcription factors and CTCF binding sites that are linked to doxorubicin resistance. Our 3Cs technology enables fast and robust generation of bias-free gene perturbation libraries with yet unmatched diversities and should be considered an alternative to established technologies.
© 2019, Wegner et al.

Entities:  

Keywords:  3Cs technology; CRISPR/Cas; DUBs; Doxorubicin; cell biology; gRNA library; genetics; genome-wide; genomics; human

Mesh:

Substances:

Year:  2019        PMID: 30838976      PMCID: PMC6424562          DOI: 10.7554/eLife.42549

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  59 in total

1.  Estimating the diversity of peptide populations from limited sequence data.

Authors:  Lee Makowski; Alexei Soares
Journal:  Bioinformatics       Date:  2003-03-01       Impact factor: 6.937

Review 2.  Overview of base excision repair biochemistry.

Authors:  Yun-Jeong Kim; David M Wilson
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

3.  A rapid and general assay for monitoring endogenous gene modification.

Authors:  Dmitry Y Guschin; Adam J Waite; George E Katibah; Jeffrey C Miller; Michael C Holmes; Edward J Rebar
Journal:  Methods Mol Biol       Date:  2010

4.  Introduction to the synthesis and purification of oligonucleotides.

Authors:  A Ellington; J D Pollard
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2001-05

5.  CTCF/cohesin-binding sites are frequently mutated in cancer.

Authors:  Riku Katainen; Kashyap Dave; Esa Pitkänen; Kimmo Palin; Teemu Kivioja; Niko Välimäki; Alexandra E Gylfe; Heikki Ristolainen; Ulrika A Hänninen; Tatiana Cajuso; Johanna Kondelin; Tomas Tanskanen; Jukka-Pekka Mecklin; Heikki Järvinen; Laura Renkonen-Sinisalo; Anna Lepistö; Eevi Kaasinen; Outi Kilpivaara; Sari Tuupanen; Martin Enge; Jussi Taipale; Lauri A Aaltonen
Journal:  Nat Genet       Date:  2015-06-08       Impact factor: 38.330

6.  A strategy for modulation of enzymes in the ubiquitin system.

Authors:  Andreas Ernst; George Avvakumov; Jiefei Tong; Yihui Fan; Yanling Zhao; Philipp Alberts; Avinash Persaud; John R Walker; Ana-Mirela Neculai; Dante Neculai; Andrew Vorobyov; Pankaj Garg; Linda Beatty; Pak-Kei Chan; Yu-Chi Juang; Marie-Claude Landry; Christina Yeh; Elton Zeqiraj; Konstantina Karamboulas; Abdellah Allali-Hassani; Masoud Vedadi; Mike Tyers; Jason Moffat; Frank Sicheri; Laurence Pelletier; Daniel Durocher; Brian Raught; Daniela Rotin; Jianhua Yang; Michael F Moran; Sirano Dhe-Paganon; Sachdev S Sidhu
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

7.  Activation of proto-oncogenes by disruption of chromosome neighborhoods.

Authors:  Denes Hnisz; Abraham S Weintraub; Daniel S Day; Anne-Laure Valton; Rasmus O Bak; Charles H Li; Johanna Goldmann; Bryan R Lajoie; Zi Peng Fan; Alla A Sigova; Jessica Reddy; Diego Borges-Rivera; Tong Ihn Lee; Rudolf Jaenisch; Matthew H Porteus; Job Dekker; Richard A Young
Journal:  Science       Date:  2016-03-03       Impact factor: 47.728

8.  Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries.

Authors:  Joana A Vidigal; Andrea Ventura
Journal:  Nat Commun       Date:  2015-08-17       Impact factor: 14.919

9.  The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible.

Authors:  Damian Szklarczyk; John H Morris; Helen Cook; Michael Kuhn; Stefan Wyder; Milan Simonovic; Alberto Santos; Nadezhda T Doncheva; Alexander Roth; Peer Bork; Lars J Jensen; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2016-10-18       Impact factor: 16.971

10.  High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity.

Authors:  Vikram Pattanayak; Steven Lin; John P Guilinger; Enbo Ma; Jennifer A Doudna; David R Liu
Journal:  Nat Biotechnol       Date:  2013-08-11       Impact factor: 54.908

View more
  9 in total

1.  Unbiased and Tailored CRISPR/Cas gRNA Libraries by SynthesizingCovalently-closed-circular (3Cs) DNA.

Authors:  Martin Wegner; Koraljka Husnjak; Manuel Kaulich
Journal:  Bio Protoc       Date:  2020-01-05

2.  Integrative analysis of epigenetics data identifies gene-specific regulatory elements.

Authors:  Florian Schmidt; Alexander Marx; Nina Baumgarten; Marie Hebel; Martin Wegner; Manuel Kaulich; Matthias S Leisegang; Ralf P Brandes; Jonathan Göke; Jilles Vreeken; Marcel H Schulz
Journal:  Nucleic Acids Res       Date:  2021-10-11       Impact factor: 16.971

3.  multicrispr: gRNA design for prime editing and parallel targeting of thousands of targets.

Authors:  Aditya M Bhagwat; Johannes Graumann; Rene Wiegandt; Mette Bentsen; Jordan Welker; Carsten Kuenne; Jens Preussner; Thomas Braun; Mario Looso
Journal:  Life Sci Alliance       Date:  2020-09-09

4.  gscreend: modelling asymmetric count ratios in CRISPR screens to decrease experiment size and improve phenotype detection.

Authors:  Katharina Imkeller; Giulia Ambrosi; Michael Boutros; Wolfgang Huber
Journal:  Genome Biol       Date:  2020-03-02       Impact factor: 13.583

Review 5.  DGK and DZHK position paper on genome editing: basic science applications and future perspective.

Authors:  Ralf P Brandes; Anne Dueck; Stefan Engelhardt; Manuel Kaulich; Christian Kupatt; Maria Teresa De Angelis; Matthias S Leisegang; Ferdinand le Noble; Alessandra Moretti; Oliver J Müller; Boris V Skryabin; Thomas Thum; Wolfgang Wurst
Journal:  Basic Res Cardiol       Date:  2021-01-15       Impact factor: 17.165

Review 6.  Functional Genomics Approaches to Elucidate Vulnerabilities of Intrinsic and Acquired Chemotherapy Resistance.

Authors:  Ronay Cetin; Eva Quandt; Manuel Kaulich
Journal:  Cells       Date:  2021-01-28       Impact factor: 6.600

7.  Metabolic Rewiring Is Essential for AML Cell Survival to Overcome Autophagy Inhibition by Loss of ATG3.

Authors:  Fatima Baker; Ibrahim H Polat; Khalil Abou-El-Ardat; Islam Alshamleh; Marlyn Thoelken; Daniel Hymon; Andrea Gubas; Sebastian E Koschade; Jonas B Vischedyk; Manuel Kaulich; Harald Schwalbe; Shabnam Shaid; Christian H Brandts
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639

8.  The caspase-2 substrate p54nrb exhibits a multifaceted role in tumor cell death susceptibility via gene regulatory functions.

Authors:  Madeleine Eichler; Ute Distler; Usman Nasrullah; Aswini Krishnan; Manuel Kaulich; Koraljka Husnjak; Wolfgang Eberhardt; Krishnaraj Rajalingam; Stefan Tenzer; Josef Pfeilschifter; Gergely Imre
Journal:  Cell Death Dis       Date:  2022-04-20       Impact factor: 9.685

9.  Covering the Combinatorial Design Space of Multiplex CRISPR/Cas Experiments in Plants.

Authors:  Kirsten Van Huffel; Michiel Stock; Tom Ruttink; Bernard De Baets
Journal:  Front Plant Sci       Date:  2022-06-20       Impact factor: 6.627

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.